Variation name (cDNA level) | Variation name (protein level) | Variation status | Variation class |
c.461G>C | p.Cys154Ser | Heterozygous | Mutation |
wt codon | wt aa | mutant codon | mutant aa | mutational event | mutation type |
TGT | Cys | TCT | Ser | G->C | Tv |
Structure | Key Residue (HCD) | Pyrimidin doublet | CpG |
EGF-like#03 | Disulfide bonds 154-166 (C2) | No | No |
At the mRNA level | On restriction map |
NA | New restriction site(s): none Lost restriction site(s): none |
Conservation (0-1) | SIFT (0-1) | UMD-predictor (0-100) |
---|---|---|
0.83 | 0.00 (pathogenous) | 82 (Pathogenous) |
Sample ID | Patient status | Gender | Transmission | Age of onset | Age of death | Geographic origin |
AUS02WES F0003 I01 | Proband | NA | NA | ? (14 years old) | AUSTRALIA |
Phenotypic group | Disease |
NA | Classical MFS |
Symptom |
C-Asc. aortic dilatation |
C-Mitral valve prolapse |
O-Ectopia lentis |
O-Ectopia lentis |
S-Crowding teeth (m) |
S-High arched palate |
S-Joint hypermobility (m) |
S-Pectus carinatum (M)(2) |
S-Reduced US/LS ratio <0.87 (M) |
SI-Significant striae atrophicae (m)(1) |
Reference ID | PubMed ID | Reference |
114 | 14695540 | Biggin A, Holman K, Brett M, Bennetts B, Ades L. "Detection of thirty novel FBN1 mutations in patients with Marfan syndrome or a related fibrillinopathy". Hum Mutat. 2004 Jan;23(1):99. |